Written by Julia Thayer, OCRA’s Associate Director, Advocacy Federal Rulemaking Update: Proposed Update to Uniform Guidance Advocacy isn’t limited to legislation and federal funding. This month, OCRA submitted a public comment on a proposed federal rule that could significantly impact how biomedical research is funded and conducted. On May 29, 2026, the Office of Management … Continued
Written by Julia Thayer, Associate Director, Advocacy FY2027 Budget Update & Advocacy Momentum As we continue through appropriations season, we wanted to share a quick update on the President’s proposed FY2027 budget and what it means for our community. While we’re still awaiting full details, there are a few key takeaways to highlight. A quick … Continued
Written by Chad Ramsey, Vice President, Policy February brought meaningful progress in Washington. From major legislative wins to the start of a new appropriations cycle, advocates are already helping shape the policy landscape for ovarian and gynecologic cancer patients in 2026 and beyond. State-Level Momentum: Biomarker Progress Continues Momentum is building across the country to … Continued
Written by Chad Ramsey, OCRA’s Vice President, Policy OCRA’s Advocate Leader Program Reaches Record Size in 2026 January marked a major milestone for Ovarian Cancer Research Alliance’s (OCRA) advocacy community. OCRA trained 94 new advocates to join our Advocate Leaders program, bringing our total to 227 advocates across 44 states and Washington, DC. This is … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance Federal Update: Government Shutdown Ends — What It Means for the Cancer Community As you are no doubt aware, after 43 days, the federal government shutdown officially ended. On November 12, 2025, President Donald J. Trump signed the temporary funding bill passed by Congress, reopening … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance Federal Update As of this writing, Congress has failed to come to an agreement on funding for the current fiscal year and the federal government is in a shutdown. We are closely monitoring the impact that the shutdown is having on the patient community and … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance As fall begins, Congress and state legislatures are facing issues with big implications for health care, research, and patient access. Here’s what’s happening now, and how you can help ensure the ovarian and gynecologic cancer community’s voice is heard. Federal Government Shutdown Upon returning … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY 2026 Appropriations & Congressional Recess: A Vital Advocacy Window As Congress continues its August recess, this “district and state work period” transforms into a strategic opportunity. Some lawmakers are focused on local engagement like town halls and community meetings, which make it the … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY26 Budget & Appropriations Update: Approaching August with Focused Advocacy As Congress advances the FY 2026 appropriations process, gynecologic cancer advocates have a key opportunity to engage. The House has delayed its markup of the Labor, Health and Human Services (Labor-HHS) Appropriations bill until after the … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY26 Budget Update: Critical Cancer Programs at Risk Congress is deep into its work on the fiscal year 2026 (FY26) appropriations bills, and decisions made now will shape the future of cancer care, prevention, and research. While there is strong bipartisan support for cancer … Continued
FY26 Budget Watch, Advocacy Results, and State-Level Progress As Congress ramps up work on the FY26 federal budget, advocates are focused on maintaining vital cancer programs and advancing state policies that support gynecologic cancer patients. Here’s what’s happened over the last month—and what’s next. Budget Update: CDC Cancer Programs at Risk The administration’s proposed FY26 … Continued
Spring is here—and so is appropriations season in Washington, DC. This month has brought key developments in both the FY26 federal budget process and state-level policy action that could impact gynecologic cancer research, prevention, and patient care. Here’s what advocates need to know: Draft Budget Proposal Would Eliminate Key CDC Cancer Programs A draft of the administration’s … Continued
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
